FROM A-LEVELS OR AN OVERSEAS DEGREE TO PRACTISING IN THE UKSearch the guide
← All news
NEW MEDICINES AND DRUG DISCOVERY · FDA: PRESS ANNOUNCEMENTS · 22 October 2026

FDA Launches New Program to Advance Neuroscience Medical Product Development

Synopsis

NAIN’s inaugural initiative, the Alzheimer's Prevention Accelerator, will focus on advancing medical products that help delay or prevent Alzheimer's disease. As its first initiative, NAIN is launching the Alzheimer's Prevention Accelerator.

Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.

Read the full story at FDA: press announcements ↗

More in New medicines and drug discovery